Graham Capital Management, L.P.

Position in ALLO — Allogene Therapeutics, Inc.

CIK 1315421 ROWAYTON, CT

Position in ALLO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$237,991

+$132,427 QoQ

Shares Held

114,419

+164.5% QoQ

Ownership

0.033%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#96

of 209 holders

Holding Since

Mar 2022

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Graham Capital Management, L.P. holds $44,243,780 across 71 Biotechnology names. ALLO ranks #28 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TVTX	Travere Therapeutics, Inc.	446,696	$25,376,799
2	INCY	Incyte Corp	15,632	$1,772,043
3	IONS	Ionis Pharmaceuticals Inc	16,717	$1,325,490
4	VKTX	Viking Therapeutics, Inc.	22,114	$862,667
5	ALNY	Alnylam Pharmaceuticals, Inc.	2,256	$679,123
6	ARVN	Arvinas, Inc.	81,364	$676,134
7	PCVX	Vaxcyte, Inc.	11,107	$645,649
8	MRVI	Maravai Lifesciences Holdings, Inc.	92,277	$575,808

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$237,991	114,419	+164.5%	Shares	Sole	2026-08-14
2026-03-31	$105,564	43,264	-70.9%	Shares	Sole	2026-05-15
2025-12-31	$203,679	148,671	-24.7%	Shares	Sole	2026-02-17
2025-09-30	$244,661	197,308	-34.7%	Shares	Sole	2025-11-14
2025-06-30	$341,565	302,270	+624.2%	Shares	Sole	2025-08-14
2024-12-31	$88,899	41,737	-33.1%	Shares	Sole	2025-02-14
2023-06-30	$310,282	62,431	+198.6%	Shares	Sole	2023-08-14
2023-03-31	$103,275	20,906	-79.9%	Shares	Sole	2023-05-15
2022-09-30	$1,122,066	103,895	-55.8%	Shares	Sole	2022-11-14
2022-06-30	$2,677,518	234,870	+63.3%	Shares	Sole	2022-08-15
2022-03-31	$1,310,291	143,830	—	Shares	Sole	2022-05-16
No filing history on record for this holder in this stock.